[HTML][HTML] Bronchopulmonary dysplasia

B Thébaud, KN Goss, M Laughon, JA Whitsett… - Nature reviews Disease …, 2019 - nature.com
In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia

E Lignelli, F Palumbo, D Myti… - American Journal of …, 2019 - journals.physiology.org
Bronchopulmonary dysplasia (BPD) is the most common cause of morbidity and mortality in
preterm infants. A key histopathological feature of BPD is stunted late lung development …

Hydrocortisone to improve survival without bronchopulmonary dysplasia

KL Watterberg, MC Walsh, L Li, S Chawla… - … England Journal of …, 2022 - Mass Medical Soc
Background Bronchopulmonary dysplasia is a prevalent complication after extremely
preterm birth. Inflammation with mechanical ventilation may contribute to its development …

European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia

L Duijts, ER van Meel, L Moschino… - European …, 2020 - Eur Respiratory Soc
This document provides recommendations for monitoring and treatment of children in whom
bronchopulmonary dysplasia (BPD) has been established and who have been discharged …

Two-year outcomes after minimally invasive surfactant therapy in preterm infants: follow-up of the OPTIMIST-A randomized clinical trial

PA Dargaville, COF Kamlin, F Orsini, X Wang… - JAMA, 2023 - jamanetwork.com
Importance The long-term effects of surfactant administration via a thin catheter (minimally
invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome …

[HTML][HTML] A review on non-invasive respiratory support for management of respiratory distress in extremely preterm infants

Y Shi, H Muniraman, M Biniwale… - Frontiers in …, 2020 - frontiersin.org
Majority of extremely preterm infants require positive pressure ventilatory support at the time
of delivery or during the transitional period. Most of these infants present with respiratory …

[HTML][HTML] The aryl hydrocarbon receptor (AHR): A novel therapeutic target for pulmonary diseases?

B Shivanna, C Chu, B Moorthy - International Journal of Molecular …, 2022 - mdpi.com
The aryl hydrocarbon receptor (AHR) is a cytoplasmic transcription factor that is well-known
for regulating xenobiotic metabolism. Studies in knockout and transgenic mice indicate that …

[HTML][HTML] Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study

I Oulego-Erroz, P Alonso-Quintela… - Journal of …, 2021 - nature.com
The objective of this study was to assess the predictive value of a lung ultrasound (LUS)
score in the development of moderate–severe bronchopulmonary dysplasia (sBPD). This …

Evaluation of trends in bronchopulmonary dysplasia and respiratory support practice for very low birth weight infants: a population-based cohort study

SM Lee, L Sie, J Liu, J Profit, HC Lee - The Journal of pediatrics, 2022 - Elsevier
Objectives To characterize the incidence of bronchopulmonary dysplasia (BPD) over time
and to test the association of multilevel factors, including respiratory support, with the …

[HTML][HTML] The value of lung ultrasound score in neonatology

H Zong, Z Huang, J Zhao, B Lin, Y Fu, Y Lin… - Frontiers in …, 2022 - frontiersin.org
Point-of-care lung ultrasound (LUS) is increasingly applied in the neonatal intensive care
unit (NICU). Diagnostic applications for LUS in the NICU contain the diagnosis of many …